Longeveron Inc.（LGVN）内部人交易：高管与董事近期交易
过去 18 个月，共有 19 位内部人为 Longeveron Inc.（LGVN）报告了 72 笔 Form 4 交易（最近一笔 2026-10-05）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-05 | Lehr Paul T | General Counsel, Secretary | 卖出 | 2,253 | $5,835 |
| 2026-10-05 | Blass Devin | CTO & SVP of CMC | 卖出 | 2,520 | $6,527 |
| 2026-10-05 | Agafonova Nataliya | Chief Medical Officer | 卖出 | 2,913 | $7,545 |
| 2026-10-05 | Jhaveri Nirav S. | Chief Financial Officer | 卖出 | 742 | $1,922 |
| 2026-10-05 | Willard Stephen H | Chief Executive Officer | 卖出 | 1,987 | $5,146 |
| 2026-08-25 | Jhaveri Nirav S. | Chief Financial Officer | 买入 | 300,000 | $0 |
| 2026-08-21 | Cann Leah Rush | 董事 | 买入 | 36,000 | $0 |
| 2026-08-21 | Ascheim Deborah | 董事 | 买入 | 36,000 | $0 |
| 2026-08-21 | Soffer Rock | 董事 | 买入 | 36,000 | $0 |
| 2026-08-21 | Lehr Paul T | General Counsel, Secretary | 买入 | 286,000 | $0 |
| 2026-08-21 | Ungaro Ursula | 董事 | 买入 | 36,000 | $0 |
| 2026-08-21 | Hare Joshua | Chief Scientific Officer | 买入 | 286,000 | $0 |
| 2026-08-21 | Agafonova Nataliya | Chief Medical Officer | 买入 | 286,000 | $0 |
| 2026-08-21 | Hajjar Roger Joseph | 董事 | 买入 | 36,000 | $0 |
| 2026-08-21 | Blass Devin | CTO & SVP of CMC | 买入 | 286,000 | $0 |
| 2026-08-21 | Paletta George A. Jr. | 董事 | 买入 | 36,000 | $0 |
| 2026-08-21 | Desai Arjun JJ | 董事 | 买入 | 36,000 | $0 |
| 2026-07-08 | Hare Joshua | Chief Scientific Officer | 买入 | 600,000 | $0 |
| 2026-07-06 | Willard Stephen H | Chief Executive Officer | 卖出 | 18,046 | $13,157 |
| 2026-07-06 | Agafonova Nataliya | Chief Medical Officer | 卖出 | 22,505 | $16,408 |
| 2026-07-06 | Locklear Lisa | Chief Financial Officer | 卖出 | 22,505 | $16,408 |
| 2026-07-06 | Blass Devin | CTO & SVP of CMC | 卖出 | 15,808 | $11,526 |
| 2026-07-06 | Lehr Paul T | General Counsel, Secretary | 卖出 | 13,143 | $9,583 |
| 2026-05-05 | Lehr Paul T | General Counsel, Secretary | 买入 | 250,000 | $0 |
| 2026-05-05 | Blass Devin | CTO & SVP of CMC | 买入 | 250,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-05